Neuphoria Therapeutics (BNOXN) Q2 2025 Earnings Report
MX:BNOXN Q2 2025 EPS Results
- Actual EPS
- ―
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- ―
MX:BNOXN Q2 2025 Revenue Results
- Actual Revenue
- ―
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 02/20/2025
- Time
- TBA
- Conference Call
- Thursday, February 20, 2025
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:BNOXN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Sep 29, 2025 | 2025 (Q4) | -36.26-45.92 | -509.96 | 91.00% (+464.04) | |
| Feb 20, 2025 | 2025 (Q2) | ―- | ― | ― | |
| Aug 21, 2024 | 2024 (Q4) | -16.55-16.55 | -18.44 | 10.23% (+1.89) | |
| Feb 22, 2024 | 2024 (Q2) | ―-18.45 | -25.67 | 28.10% (+7.21) | |
| Aug 23, 2023 | 2023 (Q4) | -19.55- | -20.13 | ― | |
| Feb 23, 2023 | 2023 (Q2) | -139.15-308.08 | -106.85 | -188.32% (-201.22) | |
| Aug 25, 2022 | 2022 (Q4) | -20364.91-241.64 | -0.16 | -153677.78% (-241.48) | |
| Feb 22, 2022 | 2022 (Q2) | -214.67-106.85 | 0 | ― | |
| Aug 25, 2021 | 2021 (Q4) | 0.00-0.16 | 0 | ― | |
| Feb 26, 2021 | 2021 (Q2) | 0.000.00 | -19.42 | 100.00% (+19.42) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
